bortezomib onkovis 3,5 mg pulver zur herstellung einer injektionslösung
onkovis gmbh (8111905) - bortezomibanhydrid - pulver zur herstellung einer injektionslösung - teil 1 - pulver zur herstellung einer injektionslösung; bortezomibanhydrid (43230) 3,336 milligramm
bortezomib denk 3,5 mg pulver zur herstellung einer injektionslösung
denk pharma gmbh & co. kg (8128863) - bortezomibanhydrid - pulver zur herstellung einer injektionslösung - teil 1 - pulver zur herstellung einer injektionslösung; bortezomibanhydrid (43230) 3,366 milligramm
abedent
baset pharma gmbh - propyphenazon, benzyl[(rs)-(hydroxy)(phenyl)acetat], paracetamol - manteltabletten - propyphenazon 275.mg; benzyl[(rs)-(hydroxy)(phenyl)acetat] 30.mg; paracetamol 165.mg
eisencluconat 300 helm-rotex
helm pharmaceuticals gmbh - eisen(ii)-gluconat (ph.eur) - manteltabletten - eisen(ii)-gluconat (ph.eur) 300.mg
eisensulfat 200 helm-rotex
helm pharmaceuticals gmbh - eisen(ii)-sulfat - manteltabletten - eisen(ii)-sulfat 192.31mg
multi-tabs helm-rotex
helm pharmaceuticals gmbh - thiaminchloridhydrochlorid, calciumpantothenat, riboflavin, nicotinamid, pyridoxinhydrochlorid, colecalciferol, retinolacetat - manteltabletten - thiaminchloridhydrochlorid 0.5mg; calciumpantothenat 1.mg; riboflavin 0.1mg; nicotinamid 5.mg; pyridoxinhydrochlorid 0.1mg; colecalciferol 200.i.e.; retinolacetat 2000.i.e.
neoveron
rosen-apotheke harro braun - propyphenazon, benzyl[(rs)-(hydroxy)(phenyl)acetat], paracetamol - manteltabletten - propyphenazon 275.mg; benzyl[(rs)-(hydroxy)(phenyl)acetat] 30.mg; paracetamol 165.mg
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
iffimed
apotheke iffezheim ursula zimmermann (0058494) - propyphenazon; benzyl[(rs)-(hydroxy)(phenyl)acetat]; paracetamol - manteltabletten - propyphenazon (908) 275 milligramm; benzyl[(rs)-(hydroxy)(phenyl)acetat] (1076) 30 milligramm; paracetamol (1212) 165 milligramm
obes tabletten gegen zahnschmerzen
cirksena-apotheke helga obes (0031532) - propyphenazon; benzyl[(rs)-(hydroxy)(phenyl)acetat]; paracetamol - manteltabletten - propyphenazon (908) 275 milligramm; benzyl[(rs)-(hydroxy)(phenyl)acetat] (1076) 30 milligramm; paracetamol (1212) 165 milligramm